Advanced Medical Solutions Grp PLC Result of AGM (2905B)

TIDMAMS

RNS Number : 2905B

Advanced Medical Solutions Grp PLC

05 June 2019

5 June 2019

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Result of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company's Annual General Meeting held today at 11am at the Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 30 April 2019.

Details of proxy votes received prior to the meeting will be made available on the Company's website at www.admedsol.com. The poll results were as follows.

 
 Resolution   For (see note 2)        Against (see 
                                       note 2) 
              No. of shares   %       No. of shares   % 
             --------------  ------  --------------  ------ 
 1            113,452,786     99.99           6,557    0.01 
             --------------  ------  --------------  ------ 
 2            108,651,443     95.58       5,019,580    4.42 
             --------------  ------  --------------  ------ 
 3            112,970,753     99.39         697,545    0.61 
             --------------  ------  --------------  ------ 
 4            112,732,404     99.17         947,555    0.83 
             --------------  ------  --------------  ------ 
 5            82,188,882      78.56      22,436,168   21.44 
             --------------  ------  --------------  ------ 
 6            108,803,775     98.06       2,149,910    1.94 
             --------------  ------  --------------  ------ 
 7            113,581,749     99.91         100,000    0.09 
             --------------  ------  --------------  ------ 
 8            87,994,990      77.99      24,831,007   22.01 
             --------------  ------  --------------  ------ 
 9            113,450,700     99.86         156,688    0.14 
             --------------  ------  --------------  ------ 
 10*          112,116,988     98.64       1,546,482    1.36 
             --------------  ------  --------------  ------ 
 11*          90,835,600      99.33         614,373    0.67 
             --------------  ------  --------------  ------ 
 

*Special Resolution

- Ends -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group plc                Tel: [phone] 
                                                                545508 
 Chris Meredith, Chief Executive Officer 
  Eddie Johnson, Chief Financial Officer 
 
 Consilium Strategic Communications               Tel: [phone] 
                                                                  5700 
 Mary-Jane Elliott / Matthew Neal / Nicholas   [e-mail] 
  Brown / Olivia Manser 
 
 Investec Bank PLC (NOMAD & Broker)               Tel: [phone] 
                                                                  5970 
 Daniel Adams / Patrick Robb / Gary Clarence 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include tissue adhesives, sutures, biosurgical devices, internal sealants, silver alginates, alginates and foams, which it markets under its brands; LiquiBand(R), LiquiBand(R) Fix 8(TM), RESORBA(R) and ActivHeal(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 630 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

RAGSSWFMIFUSEEM

(END) Dow Jones Newswires

June 05, 2019 12:29 ET (16:29 GMT)